Company profile for Debiopharm

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Debiopharm Group (Debiopharm)is a Swiss-headquartered global biopharmaceutical group including five companies active in the life science areas of drug development, GMP manufacturing of proprietary drugs, diagnostic tools and investment management. Debiopharm International SA focuses on the development of prescription drugs that target unmet medical needs. The company in-licenses and develops promising drug candidates. The prod...
Debiopharm Group (Debiopharm)is a Swiss-headquartered global biopharmaceutical group including five companies active in the life science areas of drug development, GMP manufacturing of proprietary drugs, diagnostic tools and investment management. Debiopharm International SA focuses on the development of prescription drugs that target unmet medical needs. The company in-licenses and develops promising drug candidates. The products are commercialized by pharmaceutical out-licensing partners to give access to the largest number of patients worldwide.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Forum “après-demain” Chemin Messidor 5-7 Case postale 5911 1002 Lausanne
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251117428995/en/Swiss-Based-Debiopharm-Seeks-to-Boost-Innovation-in-Japanese-Cancer-Research-Through-the-New-Ideal-Japan-Program

BUSINESSWIRE
18 Nov 2025

https://www.businesswire.com/news/home/20251106401539/en/Debiopharm-Takes-a-Step-Forward-for-Children-With-CPP-Enrollment-Completion-for-the-Phase-III-Trial-Evaluating-the-First-Ever-Yearly-Injectable-Triptorelin-Formulation

BUSINESS WIRE
06 Nov 2025

https://www.businesswire.com/news/home/20251030056511/en/Debiopharm-Forges-AI-powered-Alliance-With-NetTargets-to-Pioneer-Dual-payload-ADCs-Against-Drug-resistant-Cancers

BUSINESSWIRE
30 Oct 2025

https://www.businesswire.com/news/home/20250930083824/en/Debiopharm-Licenses-SunRock-Biopharmas-Anti-HER3HER2-Antibody-to-Explore-the-Full-Potential-of-Bispecific-ADC-Debio-2512

BUSINESSWIRE
30 Sep 2025

https://www.businesswire.com/news/home/20250826141995/en/Debiopharm-Pushes-the-Boundaries-of-Innovation-in-Antibiotic-Development-Against-Gonorrhea-with-First-In-Human-Debio-1453-Trial

BUSINESSWIRE
26 Aug 2025

https://www.businesswire.com/news/home/20250715559714/en/Repare-Therapeutics-Enters-Exclusive-Worldwide-Licensing-Agreement-with-Debiopharm-for-Lunresertib

BUSINESSWIRE
15 Jul 2025

ABOUT THIS PAGE

Contact Debiopharm and get a quotation

Debiopharm is a supplier offers 3 products (APIs, Excipients or Intermediates).

Find a price of Oxaliplatin bulk with CEP offered by Debiopharm

Find a price of Triptorelin Pamoate bulk with DMF offered by Debiopharm

Find a price of Oxaliplatin bulk offered by Debiopharm

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty